Shay Capital’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RLMD
JHC
Shay Capital's RLMD Position: Q3 2026 in Review
Shay Capital opened a new position in Relmada Therapeutics (RLMD) in Q3 2026: 18,014 shares worth $67.9K. The stake represents ﹤0.01% of the portfolio and ranks #469 among its holdings. This is a return to the name: Shay Capital previously reported a position in RLMD as recently as Q3 2024.
Shay Capital first reported a position in RLMD in Q3 2024 and has held it in 2 quarters since. The position peaked at $569K in Q3 2024. 105 funds tracked by Wall St. Rank hold RLMD as of Q3 2026.
- Shay Capital held 18,014 shares of Relmada Therapeutics worth $67.9K as of Q3 2026.
- Relmada Therapeutics was a new Shay Capital position in Q3 2026.
- Relmada Therapeutics made up ﹤0.01% of Shay Capital's portfolio in Q3 2026, its #469 holding.
- Shay Capital first reported a position in Relmada Therapeutics in Q3 2024 and has held it in 2 quarters since.
- Shay Capital's Relmada Therapeutics position peaked at $569K in Q3 2024.
- 105 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q3 2026.
Based on Shay Capital's 13F filing for Q3 2026, filed 16 Nov 2026.